Emerging pharmacological therapies for ARDS: COVID-19 and beyond
Sign Up to like & getrecommendations! Published in 2020 at "Intensive Care Medicine"
DOI: 10.1007/s00134-020-06141-z
Abstract: ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory failure. Despite considerable advances in our knowledge regarding the pathophysiology of ARDS, insights into the biologic mechanisms of lung injury and… read more here.
Keywords: medicine; pharmacological therapies; ards covid; therapies ards ... See more keywords
Pharmacologic therapies of ARDS: From natural herb to nanomedicine
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.930593
Abstract: Acute respiratory distress syndrome (ARDS) is a common critical illness in respiratory care units with a huge public health burden. Despite tremendous advances in the prevention and treatment of ARDS, it remains the main cause… read more here.
Keywords: natural herb; ards natural; herb nanomedicine; therapies ards ... See more keywords